Analisi facoltativa del prodotto
Con il tuo consenso utilizziamo analisi limitate e rispettose della privacy per capire quali percorsi di ricerca funzionano. Non usiamo tracker pubblicitari né registrazioni delle sessioni. Puoi modificare questa scelta nelle Preferenze. Leggi la Informativa sulla privacy.
The strongest opportunity is that FY2027 diluted EPS holds within its forecast range while annual free cash flow remains positive after capital spending.
Pre-tax cost of debt above 9.35% within 24 months.
Hold. At the report-date price of $83.43 on 2026-09-04, the shares sit below Fair value of $87.41, but the gap is modest.3
The main risk is refinancing. If pre-tax debt cost rises above 9.35% within 24 months, financing expense could absorb growth and weaken free cash flow.
Potential value is $121.21, but it requires stronger free cash flow after capital spending and durable earnings growth.
The clearest upside is that FY2027 diluted EPS stays within its $4.23-$4.68 forecast range while annual remains positive after capital spending.
Demand is constructive through FY2027 if annual revenue forecasts are met. Industry evidence also shows high reinvestment, with capex at 33.6% of revenue and 3.15 times depreciation.
Hold because the supported two-year revenue runway is largely balanced by leverage and investment-conversion risk.
Demand is constructive through FY2027 if annual revenue forecasts are met. Industry evidence also shows high reinvestment, with capex at 33.6% of revenue and 3.15 times depreciation.
Hold because substantial debt and heavy investment limit the value of the supported outlook until revenue produces earnings per share and free cash flow after capital spending.
The most damaging path combines higher refinancing costs, weaker margins and negative annual free cash flow. Debt then absorbs more operating growth while investment needs force additional borrowing or dilution.
Higher refinancing costs and weaker margins increase external funding needs. This path is confirmed by breaches in debt cost, annual free cash flow or operating margin within 24 months.
If the pre-tax cost of debt moves above 9.35% within 24 months, higher financing expense could absorb operating growth while the investment programme remains capital intensive.23
I cinque sviluppi che indebolirebbero la nostra tesi d'investimento.
Higher refinancing expense would consume more operating profit and reduce funding flexibility during the capital programme.
Attuale:8.35% as of 2026-09-08
Avviso seAbove 9.35% within 24 months
FY2025 operating cash flow and free cash flow show operating performance, but they do not establish customer protection, switching barriers, franchise rights or a cost advantage. Structural durability therefore remains unresolved.
Positive FY2025 operating cash flow and free cash flow do not by themselves prove lasting excess returns. Without evidence of structural protection, the duration of value creation remains unresolved.45
Each lens answers a different valuation question. Only included lenses set Fair value; floors and diagnostics provide context.
The highlighted cell is Fair value when every assumption sits at its base level ($87.41). Each row and column shows what Fair value becomes when one assumption moves.
Free cash flow to the firm stays positive in the first projected year at $6.0B after modeled reinvestment of $2.4B, with terminal value at 57.3% of enterprise value. A sudden drop in free cash flow is not projected unless capital spending relative to revenue, reinvestment, or gross margin resets materially.
Revenue growth must translate into higher diluted earnings per share while annual free cash flow after capital spending stays positive. The path fails if FY2027 diluted EPS falls below its forecast range or annual free cash flow turns negative.
Revenue growth must produce diluted EPS and free cash flow after capital spending. Extra share issuance would spread earnings across more shares and dilute existing holders.
Matching forecasts preserves the thesis but does not resolve financing risk.
That would increase reliance on external financing while debt remains substantial.
FY2025 operating cash exceeded reported profit, but substantial debt keeps financing risk separate.35
FY2025 operating cash flow remained positive after heavy capital spending, but free cash flow was much smaller. A fall below zero would signal greater external funding needs.45
Capital allocation is expansion-led. Capex stayed elevated across FY2023-FY2025, while debt reached $95.62 billion in FY2025. Better free cash flow must accompany any slower investment phase.
The admissible evidence does not establish a dated return-on-invested-capital trajectory. Heavy investment means future returns depend on new assets producing cash without proportional financing needs.
A supported company return comparison is not available; the dated WACC was 7.4345% on 2026-09-08.
Operating cash flow was $12.49 billion versus net income of $6.84 billion.
The earnings base is credible, but this does not remove leverage risk.
FY2025 capex was $9.27 billion and free cash flow was $3.21 billion.
Value depends on the build producing future cash rather than merely expanding assets.
| Ricavi | 27.476.000.000 USD |
|---|---|
| Costo del venduto | 10.221.000.000 USD |
| Utile lordo | 17.255.000.000 USD |
| Costi operativi | 8.975.000.000 USD |
| Reddito operativo | 8.280.000.000 USD |
| Voci non operative e imposte | -1.445.000.000 USD |
| Utile netto | 6.835.000.000 USD |
| Attività totali | 212.721.000.000 USD |
|---|---|
| Disponibilità liquide | 2.812.000.000 USD |
| Attività correnti | 13.584.000.000 USD |
| Passività totali | 146.242.000.000 USD |
| Passività correnti | 22.817.000.000 USD |
| Patrimonio netto | 66.479.000.000 USD |
| Utile netto | 6.835.000.000 USD |
|---|---|
| Afflusso operativo | 13.415.000.000 USD |
| Ammortamenti e svalutazioni | 6.580.000.000 USD |
| Flusso di cassa operativo | 12.485.000.000 USD |
| Deflusso operativo | 930.000.000 USD |
| Liquidità disponibile | 26.871.000.000 USD |
| Liquidità iniziale | 1.402.000.000 USD |
| Afflusso da finanziamenti | 12.979.000.000 USD |
| Effetto dei tassi di cambio | 5.000.000 USD |
| Deflusso da investimenti | 23.865.000.000 USD |
| Capex | 9.274.000.000 USD |
| Altre attività di investimento | 14.591.000.000 USD |
| Liquidità finale | 3.006.000.000 USD |
| Flusso da investimenti | -23.865.000.000 USD |
| Flusso da finanziamenti | 12.979.000.000 USD |
Dati finanziari puntuali utilizzati nell’analisi del 2026-09-08.
| Periodo | Ricavi | EBITDA | Utile netto | Flusso di cassa operativo | Flusso di cassa libero | Capex | Ammortamenti e svalutazioni | Compensi basati su azioni | Riacquisti di azioni | Dividendi pagati | Emissione netta di debito | Flusso da investimenti | Flusso da finanziamenti | Liquidità iniziale | Liquidità finale | Liquidità e investimenti | Debito totale | Margine operativo | ROIC | WACC | Differenziale ROIC−WACC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2016-12-31 | 16,1 Mld USD | 8,9 Mld USD | 2,9 Mld USD | 6,4 Mld USD | 2,1 Mld USD | 4,2 Mld USD | 3,1 Mld USD | 77 Mln USD | — | 1,6 Mld USD | — | -8 Mld USD | 2,4 Mld USD | — | 1,5 Mld USD | 1,3 Mld USD | 30,8 Mld USD | 27,6% | — | 2,9% | — |
| 2017-12-31 | 17,2 Mld USD | 8,9 Mld USD | 5,4 Mld USD | 6,5 Mld USD | 1 Mld USD | 5,4 Mld USD | 2,4 Mld USD | 76 Mln USD | — | 1,8 Mld USD | — | -8,9 Mld USD | 2,9 Mld USD | 1,5 Mld USD | 2 Mld USD | 1,7 Mld USD | 35,1 Mld USD | 30,1% | — | 3,8% | — |
| 2018-12-31 | 16,7 Mld USD | 13 Mld USD | 6,6 Mld USD | 6,6 Mld USD | 583 Mln USD | 6 Mld USD | 3,9 Mld USD | 82 Mln USD | — | 2,1 Mld USD | — | -11 Mld USD | 7,6 Mld USD | 2 Mld USD | 5,3 Mld USD | 638 Mln USD | 37,7 Mld USD | 25,6% | — | 3,6% | — |
| 2019-12-31 | 19,2 Mld USD | 10,6 Mld USD | 3,8 Mld USD | 8,2 Mld USD | -2,9 Mld USD | 11,1 Mld USD | 4,2 Mld USD | -108 Mln USD | — | 2,4 Mld USD | — | -16,2 Mld USD | 3,9 Mld USD | 5,3 Mld USD | 1,1 Mld USD | 600 Mln USD | 42,6 Mld USD | 27,9% | — | 3,4% | — |
| 2020-12-31 | 18 Mld USD | 8,7 Mld USD | 2,9 Mld USD | 8 Mld USD | 224 Mln USD | 7,8 Mld USD | 4,1 Mld USD | 2 Mld USD | — | 2,7 Mld USD | — | -13,7 Mld USD | 6,2 Mld USD | 1,1 Mld USD | 1,5 Mld USD | 6,8 Mld USD | 48,1 Mld USD | 28,4% | — | 2,7% | — |
| 2021-12-31 | 17,1 Mld USD | 8,1 Mld USD | 3,6 Mld USD | 7,6 Mld USD | -277 Mln USD | 7,8 Mld USD | 3,9 Mld USD | 1,6 Mld USD | — | 3 Mld USD | — | -13,6 Mld USD | 5,8 Mld USD | 1,5 Mld USD | 1,3 Mld USD | 639 Mln USD | 54,8 Mld USD | 17,1% | — | 3,6% | — |
| 2022-12-31 | 21 Mld USD | 9 Mld USD | 4,1 Mld USD | 8,3 Mld USD | -1,5 Mld USD | 9,7 Mld USD | 4,5 Mld USD | 142 Mln USD | — | 3,4 Mld USD | 10,3 Mld USD | -18,4 Mld USD | 12,2 Mld USD | 1,3 Mld USD | 3,4 Mld USD | 1,6 Mld USD | 65 Mld USD | 19,5% | — | 5,5% | — |
| 2023-12-31 | 28,1 Mld USD | 16,8 Mld USD | 7,3 Mld USD | 11,3 Mld USD | 1,8 Mld USD | 9,5 Mld USD | 5,9 Mld USD | 139 Mln USD | — | 3,8 Mld USD | 8,2 Mld USD | -23,5 Mld USD | 12,1 Mld USD | 3,4 Mld USD | 3,4 Mld USD | 2,7 Mld USD | 73,2 Mld USD | 36,4% | — | 5,5% | — |
| 2024-12-31 | 24,8 Mld USD | 14 Mld USD | 6,9 Mld USD | 13,3 Mld USD | 4,7 Mld USD | 8,5 Mld USD | 5,5 Mld USD | — | — | 4,2 Mld USD | 11,6 Mld USD | -22,3 Mld USD | 7 Mld USD | 3,4 Mld USD | 1,4 Mld USD | 1,5 Mld USD | 82,3 Mld USD | 30,2% | — | 6,3% | — |
| 2025-12-31 | 27,5 Mld USD | 16,2 Mld USD | 6,8 Mld USD | 12,5 Mld USD | 3,2 Mld USD | 9,3 Mld USD | 6,6 Mld USD | — | — | 4,7 Mld USD | 13,7 Mld USD | -23,9 Mld USD | 13 Mld USD | 1,4 Mld USD | 3 Mld USD | 2,8 Mld USD | 95,6 Mld USD | 30,1% | — | 6,7% | — |
NextEra Energy Inc. (NEE) trades at 19.3x forward earnings against a peer median of 17.6x. Its EV/EBITDA of 20.0x compares with a peer median of 13.3x. The comparison uses 4 peers: Constellation Energy Corporation, Dominion Energy Inc., The Southern Company and Duke Energy Corporation, as of 2026-09-08.
FY2025 capex was $9.27 billion, while the industry benchmark was 33.6% of revenue and 3.15 times depreciation.3
Demand is constructive through FY2027 if annual revenue forecasts are met. Industry evidence also shows high reinvestment, with capex at 33.6% of revenue and 3.15 times depreciation.
The cycle turns harmful if refinancing costs rise while heavy capital spending continues before new assets generate enough cash. This is a conditional risk grounded in FY2025 debt, cash and capex, not an observed outcome.
NEE enters this phase with positive FY2025 free cash flow, but substantial debt makes execution and financing costs decisive.34
Maintain existing exposure; no portfolio percentage is established. At the September 4, 2026 report-date price, the shares are below the $87.41 Fair value, but the gap is modest. Do not increase exposure until revenue growth translates into higher diluted earnings per share and free cash flow stays positive after capital spending. FY2025 debt was $95.62 billion versus $2.81 billion of cash, and capital spending was $9.27 billion.1345
Keep exposure unchanged. Reduce if pre-tax debt cost rises above 9.35% within 24 months, annual free cash flow falls below zero, FY2027 diluted EPS falls below $4.23, or GAAP operating margin falls below 27.14%. These breaches would show higher financing burdens or weaker conversion of revenue into earnings and cash after capital spending.
The report-date price is below Fair value, but the gap is modest and leverage remains material.3
Do not initiate solely on forecast revenue growth; wait for stronger evidence that investment converts into free cash flow.4
High debt, heavy capital spending and refinancing exposure may not fit a defensive mandate.3
Hold existing exposure; do not add solely because FY2026-FY2027 revenue forecasts remain constructive.1
Annual revenue forecasts remain constructive through FY2027. FY2025 operating and free cash flow were positive, but debt and capital spending remained substantial. Evidence does not establish long-lasting structural protection.
Capture your own thesis, position size, and follow-up questions. Stays on this device, only you can see it.
The records this analysis drew on, as they stood when it was run.
Not every cited input appears here: internal calculations and intermediate model outputs have no external record, and some citations could not be matched to one.
A fall below zero within 24 months would show that investment spending no longer funds itself, increasing reliance on debt or new shares.34
A GAAP operating margin below 27.14% within 24 months would show that forecast revenue is arriving with weaker profit, reducing cash available for reinvestment and shareholders.35
Weaker cash after capital spending would increase reliance on debt or new shares. Issuing new shares would dilute existing holders and reduce their share of future earnings.
Attuale:$3.21 billion in FY2025
Avviso seBelow $0 within 24 months
Lower profit on each dollar of revenue would reduce earnings and cash available to fund the build.
Attuale:30.14% in FY2025
Avviso seBelow 27.14% within 24 months
Revenue growth must produce diluted EPS, not just higher sales. Weaker diluted EPS would leave less profit for each share and shorten the supported earnings-growth period.
Attuale:Mean forecast of $4.39 as of 2026-09-08
Avviso seBelow $4.23 by FY2027
Slower growth would remove support for extending the revenue path beyond FY2027 and would require lower earnings assumptions.
Attuale:Forecast of 11.78% as of 2026-09-08
Avviso seBelow 8% in FY2027
Limitation: Terminal value is 63.2% of this model's value, above the 60% level at which the methodology flags concentration; the value leans on the years beyond the explicit forecast.
Under the moderate discount rate, 31,68 USD comes from forecast-period earnings and 58,57 USD from the long-term value, totaling 90,25 USD.
Project EPS through the explicit advantage period, fade growth as competition catches up, and discount the full stream at cost of equity.
Limitation: Terminal value is 77.7% of this model's value, above the 60% level at which the methodology flags concentration; the value leans on the years beyond the explicit forecast.
Apply a terminal P/E to the dated forward EPS path, then discount that future share value back to the analysis date.
Add depreciation to net income, subtract maintenance capex, divide by diluted shares, and apply a normalized valuation multiple.
Multiply the peer median PEG by this stock's forecast growth to derive an implied forward P/E, then apply it to forward EPS.
Solve for the growth rate that makes the model value equal the report-date share price.
Upside persists if FY2027 diluted EPS remains within its forecast range and annual free cash flow improves after capital spending. It fades if EPS falls below that range or free cash flow turns negative.
Negative cash after investment would increase financing needs.4
Higher borrowing costs would absorb profit and reduce funding flexibility.2
A shortfall would weaken the supported growth runway.1
| FY2035 |
|---|
| Revenue | $31.15B | $34.82B | $37.26B | $39.12B | $40.29B | $41.50B | $42.75B | $44.03B | $45.35B | $46.71B |
| Revenue growth | 13.4% | 11.8% | 7.0% | 5.0% | 3.0% | 3.0% | 3.0% | 3.0% | 3.0% | 3.0% |
| Operating margin | 30.1% | 30.1% | 30.1% | 30.1% | 30.1% | 30.1% | 30.1% | 30.1% | 30.1% | 30.1% |
| Operating income | $9.39B | $10.49B | $11.23B | $11.79B | $12.14B | $12.51B | $12.88B | $13.27B | $13.67B | $14.08B |
| Tax rate | 10.1% | 10.1% | 10.1% | 10.1% | 10.1% | 10.1% | 10.1% | 10.1% | 10.1% | 10.1% |
| NOPAT | $8.44B | $9.43B | $10.10B | $10.60B | $10.92B | $11.25B | $11.58B | $11.93B | $12.29B | $12.66B |
| Reinvestment | $2.44B | $2.05B | $1.46B | $767.21M | $0.00 | $1.01B | $2.08B | $3.22B | $4.42B | $5.68B |
| Reinvestment rate (of NOPAT) | 29.0% | 21.7% | 14.5% | 7.2% | 0.0% | 9.0% | 18.0% | 27.0% | 35.9% | 44.9% |
| Depreciation and amortization | $7.46B | $8.34B | $8.92B | $9.37B | $9.65B | $9.94B | $10.24B | $10.54B | $10.86B | $11.19B |
| Free cash flow to firm | $6.00B | $7.39B | $8.63B | $9.83B | $10.92B | $10.24B | $9.50B | $8.72B | $7.87B | $6.97B |
| Terminal growth | 3.0% | 3.0% | 3.0% | 3.0% | 3.0% | 3.0% | 3.0% | 3.0% | 3.0% | 3.0% |
| Diluted shares | 2.09B | 2.11B | 2.13B | 2.15B | 2.17B | 2.19B | 2.22B | 2.24B | 2.26B | 2.28B |
| EPS | $3.84 | $4.39 | $4.55 | $4.63 | $4.61 | $4.70 | $4.80 | $4.90 | $4.99 | $5.09 |
| Net margin | 25.7% | 26.6% | 26.0% | 25.5% | 24.9% | 24.9% | 24.9% | 24.9% | 24.9% | 24.9% |
| Implied net income | $8.02B | $9.27B | $9.70B | $9.96B | $10.02B | $10.33B | $10.64B | $10.95B | $11.28B | $11.62B |
| Margine |
|---|
| NEE | NextEra Energy Inc. | $174.0B | 19.3x | 6.1x | 20.0x | 11.7% | — |
| CEG | Constellation Energy Corporation | 22.4x | 3.4x | 16.4x | 15.1% | 8.7% | |
| D | Dominion Energy Inc. | 17.3x | 3.2x | 14.1x | 8.3% | 29.2% | |
| SO | The Southern Company | 17.9x | 3.4x | 12.5x | 11.5% | 29.6% | |
| DUK | Duke Energy Corporation | 16.8x | 2.9x | 11.3x | 9.9% | 27.5% |
| Annual free cash flow | Below zero | Reduce exposure if annual free cash flow falls below zero. The breach would reverse FY2025's positive cash generation after capital spending and require more external financing. |
